UNSPSC 51283941: Sulfacetamide sodium

This classification denotes a sulfonamide anti-infective agent with the molecular formula C8H9N2O3S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4NRT660KJQ, chemically known as sulfanilamide, n(sup 1)-acetyl- but more generally known as sulfacetamide sodium, which bears US NIH Compound Identifier 5320. European Medicines Agency schedules Sulfacetamide sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04620MIG.

Most nations, for tariff and trade purposes, schedule sulfacetamide sodium under HS 29350090 and SITC 51580. As of Q4 2014, SULFACETAMIDE SODIUM remains US FDA's Preferred Term for this commodity. Sulfacetamide sodium bears US NLM identifiers UMLS ID C0282356 and NCI Concept Code C29467. SMILES: CC(=O)[N-]S(=O)(=O)C1CCC(CC1)N.O.[NA+].

UNSPSC 51283941 Sulfacetamide sodium is a Commodity code that nominally describes a topical antibiotic pharmaceutical, but recent state and local contract opportunities show little direct procurement activity matching the specific drug name. The two most recent records—an Illinois Department of Public Health pharmaceutical warehouse piggyback contract awarded to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems—do not align with sulfacetamide sodium as a product category. State and local health departments and county procurement offices do source pharmaceutical products through cooperative purchasing consortia and competitive bidding, but the available records suggest this specific code either receives minimal use or is applied inconsistently to broader pharmaceutical procurement activity. The Illinois Department of Public Health has used piggyback contracting through MMCAP Infuse with vendors like Chartwell Rx LLC to supply antibiotics and other drugs in bulk, supporting a pattern of centralized pharmaceutical sourcing by state health agencies.

Geographic activity appears concentrated in the Southeast and Midwest based on the recent records, with Seminole County, Florida and Illinois Department of Public Health representing the visible procurement bodies. The Illinois award to Chartwell Rx LLC was a $2,999,999.11 contract over three years for antibiotic supply through an IFB process, while Seminole County's IFB60459723LAS sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. Neither opportunity directly procured sulfacetamide sodium, suggesting the code may see limited application in recent state and local purchasing or that opportunities under this specific drug code are not well represented in current posting records.